Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The Citadel Embolization Device Study
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular’s Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Location: CPMC (San Francisco: Davies Campus)
Please contact: ClinicalResearch@sutterhealth.org about study CITADEL
Principal Investigator
Co-Investigator(s)
Fabio Settcase, M.D., M.S., FRCPC, Warren T Kim, M.D., Ph.D.
Related Studies
GXCA
Gene Expression of Cerebral Aneurysms // [EMC]
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Use EHRs and survey data to characterize migraineurs at Sutter Health by demographic, comorbidity, symptom, and care gap profiles, to see if tx needs are met.
Mindfulness and Migraine: A Randomized Controlled Trial
Conduct a randomized controlled feasibility trial of mindfulness-based stress reduction for patients with moderate-to-severe migraine headache.
Investigator: Sylvia Sudat, PhD
Genetics and Comorbidity of Migraine
Identify common genetic variants for migraine to determine whether there are single nucleotide polymorphisms associated with migraine.